Skip to content
DataLookout
Menu

VIT-D-PNEUMONINCT07938489

Effect of Single High-Dose Vitamin D3 Versus Placebo on Hospital Length of Stay in Children With Severe Pneumonia.

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Mean Hospital Length of Stay
Timeframe: From hospital admission until discharge (3-14 days).

Arms and interventions

Vitamin D3 GroupExperimental

Participants allocated to this group will receive a single high oral dose of 200,000 IU vitamin D3 dissolved in a 10 mL peanut oil solution. The intervention will be administered to children presenting with severe pneumonia. Participants will be followed during their hospital stay, and the duration from admission to discharge will be recorded in days.

Placebo GroupPlacebo comparator

Participants allocated to this group will receive 10 mL of peanut oil solution as placebo. The placebo preparation will be identical to the vitamin D3 solution in color, taste, smell, consistency, and container. Participants will be followed during their hospital stay, and the duration from admission to discharge will be recorded in days.

Drugs: Vitamin D3 Group, Placebo (Peanut Oil Solution)

Sites

1 site in 1 country

  • Department of Pediatircs, Mohtarma Benazir Bhutto Shaheed Hospital, Mirpur AJ&KLahore, Punjab Province, Pakistan